Neuromyelitis optica following human papillomavirus vaccination
- 17 July 2012
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 79 (3), 285-287
- https://doi.org/10.1212/wnl.0b013e31825fdead
Abstract
The quadrivalent human papillomavirus (HPV) vaccine Gardasil (Merck & Co., Whitehouse Station, NJ) (qHPV-vac) was recently approved for immunization of adolescent girls to prevent cervical cancer.[1][1] Recently, 5 cases of multiple sclerosis (MS) were reported following qHPV-vac vaccination.[2][2]This publication has 7 references indexed in Scilit:
- CNS demyelination and quadrivalent HPV vaccinationMultiple Sclerosis Journal, 2009
- Seroprevalence of 34 Human Papillomavirus Types in the German General PopulationPLoS Pathogens, 2008
- The spectrum of neuromyelitis opticaThe Lancet Neurology, 2007
- Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil??)Drugs, 2006
- HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole bloodVaccine, 2005
- An open label study of the effects of rituximab in neuromyelitis opticaNeurology, 2005
- Recombinant hepatitis B vaccine and the risk of multiple sclerosisNeurology, 2004